POSTOPERATIVE ADJUVANT TREATMENT

Clinical trials for POSTOPERATIVE ADJUVANT TREATMENT explained in plain language.

Never miss a new study

Get alerted when new POSTOPERATIVE ADJUVANT TREATMENT trials appear

Sign up with your email to follow new studies for POSTOPERATIVE ADJUVANT TREATMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for head & neck cancer patients who Can't take standard chemo

Disease control Not yet recruiting

This study is for people with high-risk head and neck cancer who have had surgery but cannot take the standard chemotherapy drug cisplatin. It will test if adding two newer drugs (nimotuzumab and bemcentinib) to standard radiation therapy after surgery is better at keeping the ca…

Matched conditions: POSTOPERATIVE ADJUVANT TREATMENT

Phase: PHASE3 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control

Last updated Mar 16, 2026 15:27 UTC

POSTOPERATIVE ADJUVANT TREATMENT

Get alerted when new POSTOPERATIVE ADJUVANT TREATMENT trials appear

New hope for head & neck cancer patients who Can't take standard chemo